Orphengesic Drug Interactions
Currently displaying 90 drugs known to have a major interaction with Orphengesic (aspirin / caffeine / orphenadrine).
- 90 major drug interactions
- 623 moderate drug interactions
- 26 minor drug interactions
Major interactions with Orphengesic (aspirin / caffeine / orphenadrine)
Note: Showing generic names only.
A
- abrocitinib
- acalabrutinib
- acetazolamide
- ado-trastuzumab emtansine
- aducanumab
- alfentanil
- anisindione
- apixaban
- ardeparin
- avapritinib
B
C
D
- dabigatran
- dalteparin
- danaparoid
- dasatinib
- deferasirox
- defibrotide
- desirudin
- dezocine
- dichlorphenamide
- dicumarol
- donanemab
- dorzolamide ophthalmic
- drotrecogin alfa
E
F
H
I
- ibritumomab
- ibrutinib
- ibuprofen
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, live
- inotersen
- iodine i 131 tositumomab
K
L
M
N
O
P
- panobinostat
- pentazocine
- plasminogen, human
- ponatinib
- potassium chloride
- potassium citrate
- propoxyphene
R
S
T
- tapentadol
- teriflunomide
- tinzaparin
- tipranavir
- tizanidine
- topiramate
- tositumomab
- tovorafenib
- tramadol
W
Z
Orphengesic alcohol/food interactions
There are 5 alcohol/food interactions with Orphengesic (aspirin / caffeine / orphenadrine).
Orphengesic disease interactions
There are 19 disease interactions with Orphengesic (aspirin / caffeine / orphenadrine) which include:
- coagulation
- cardiac disease
- hypertension
- psychiatric disorders
- PUD
- asthma
- anticholinergic effects
- GI toxicity
- renal dysfunction
- Reye's syndrome
- cardiotoxicity
- liver disease
- renal dysfunction
- seizure disorders
- GERD
- anemia
- dialysis
- G-6-PD deficiency
- hepatotoxicity
More about Orphengesic (aspirin / caffeine / orphenadrine)
- Orphengesic consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- Drug class: skeletal muscle relaxant combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.